Clinical Pharmacology and Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Distributed and Secure Software (DistriNet), Department of Computer Science, KU Leuven, Leuven, Belgium.
BMC Med Inform Decis Mak. 2022 Nov 17;22(1):296. doi: 10.1186/s12911-022-02039-6.
The development of technological applications in clinical research, such as electronic informed consent (eIC), is on the rise. The involvement of end users throughout the design process of eIC is of utmost importance to improve the current informed consent process.
Using a provocative design, we conducted interviews with 30 clinical research participants. Provotypes were used as a starting base to discuss various aspects relevant to eIC. By providing a medium to encourage divergent thinking, participants' views and concerns were solicited. Thematic analysis was undertaken using NVivo.
The majority of participants placed trust in the principal investigator or the hospital to perform the role of eIC hosting party. Differing opinions were reported on the amount of information required related to stakeholders' access to an eIC system, and thus, to participants' personal data, to enable trust in an eIC system. Nevertheless, this study indicates a general willingness of participants to share personal data with physicians and pharmaceutical companies on an international level, and to receive requests for new research studies via an eIC system. Participants suggested to tailor an eIC system based upon their preferences, for example, regarding whom they want to share their personal data with. Moreover, they expressed a desire to choose how they can contact the research team, and to indicate which study-related information they would like to receive electronically. In addition, positive opinions were voiced on the integration of a test to assess participants' understanding before providing their eIC.
Following a research through design approach, insights have been generated which inform the design of eIC. Provotypes were designed to help participants think beyond what is familiar to them. Study findings revealed that not all situations were perceived as provocative, because of participants' motivation to advance scientific research and the trust they place in the research team. Nevertheless, the use of provocative design resulted in additional insights, generated by clinical research participants, which could be considered in the further design of eIC.
电子知情同意书(eIC)等临床研究技术应用的发展方兴未艾。在 eIC 的设计过程中让终端用户全程参与对于改进现行知情同意流程至关重要。
采用激发式设计,我们对 30 名临床研究参与者进行了访谈。原型作为讨论 eIC 相关各方面的起点。通过提供鼓励发散思维的媒介,征求了参与者的意见和顾虑。使用 NVivo 进行主题分析。
大多数参与者信任主要研究者或医院作为 eIC 托管方。对于与利益攸关方访问 eIC 系统相关的所需信息数量,以及由此产生的对 eIC 系统的信任,存在不同意见。然而,本研究表明,参与者普遍愿意在国际层面上与医生和制药公司共享个人数据,并通过 eIC 系统收到新研究的请求。参与者建议根据自己的喜好定制 eIC 系统,例如,他们希望与谁共享个人数据。此外,他们表示希望选择如何与研究团队联系,并指定他们希望以电子方式接收哪些与研究相关的信息。此外,人们对在提供电子知情同意前进行评估参与者理解程度的测试的整合表示了积极的看法。
通过研究型设计方法,获得了有关 eIC 设计的信息。原型的设计旨在帮助参与者跳出固有思维。研究结果表明,并非所有情况都被视为具有激发性,因为参与者有推进科学研究的动力,并且对研究团队有信心。然而,使用激发式设计产生了额外的见解,这些见解是由临床研究参与者提出的,在进一步设计 eIC 时可以考虑这些见解。